FORE Biotherapeutics Presents Phase 1/2a Plixorafenib Data Demonstrating Prolonged Duration of Effect in BRAF Altered Thyroid Cancers at American Thyroid Association® 2025 Annual Meeting
Plixorafenib demonstrated mPFS of 64 months and a clinical benefit rate of 85.7% in patients with MAPKi-naïve BRAF V600-mutated papillary thyroid cancer, a potential... Read more.
$100 Million Tennessee Members 1st Federal Credit Union Partners with Credit Union Wealth Group to Offer Financial Advice & Investments to Membership
OAK RIDGE, Tenn.–(BUSINESS WIRE)–#banking–Tennessee Members 1st Federal Credit Union (TN Members 1st) is proud to announce a partnership with Credit... Read more.
Mandos Health to Present New Analyses in Niemann-Pick Disease Type C at the 2025 American Neurological Association Annual Meeting
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Mandos Health® by Beren Therapeutics Public Benefit Corporation (P.B.C.) announced today that new analyses detailing... Read more.
NEOGEN 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Neogen Corporation – NEOG
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles... Read more.
Western Alliance Bancorporation Announces $300 Million Share Repurchase Program
PHOENIX–(BUSINESS WIRE)–Western Alliance Bancorporation (NYSE: WAL) today announced its Board of Directors authorized the repurchase of up to $300 million... Read more.
SUI Group Announces Completion of Existing $2 Million Stock Repurchase Program and Subsequent Authorization of New $50 Million Program
WAYZATA, Minn.–(BUSINESS WIRE)–SUI Group Holdings Limited (“SUI Group,” “SUIG” or the “Company”) (NASDAQ: SUIG), the only publicly traded... Read more.
Real World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Developmental Medicine and Child Neurology
— Findings reinforce efficacy and tolerability profile in patients prescribed DAYBUE in the U.S. for as long as 12 months, consistent with the Phase 3 LAVENDER™... Read more.
Bentley Systems, Incorporated Declares Third Quarter 2025 Dividend
EXTON, Pa.–(BUSINESS WIRE)–Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that its Board... Read more.
Ralph Lauren Corporation Declares Quarterly Dividend
NEW YORK–(BUSINESS WIRE)–Ralph Lauren Corporation (NYSE: RL) announced that its Board of Directors has declared a regular quarterly dividend of $0.9125... Read more.
MavenAI and Engrain Announce Partnership to Automate All-In Apartment Pricing for Renters
MADISON, Wis.–(BUSINESS WIRE)–MavenAI, the leader in automated multifamily marketing solutions, has partnered with Engrain, the leader in interactive... Read more.